ILMN · US market
ILLUMINA INC
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$40.12bnFinancials dated 28 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- US$825.00m
- Latest-quarter run-rate earnings
- US$828.00m
- Latest fiscal-year earnings
- US$850.00m
- Trailing revenue
- US$4.49bn
- Latest-quarter run-rate revenue
- US$4.64bn
- Latest fiscal-year revenue
- US$4.34bn
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- IBBQ · Invesco Nasdaq Biotechnology ETF5.37% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- PBE · Invesco Biotechnology & Genome ETF5.37% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- ARKG.L · ARK Genomic Revolution UCITS ETF5.07% weight · Holdings dated 3 August 2026
- EKG · First Trust Nasdaq Lux Digital Health Solutions ETF5.00% weight · Holdings dated 30 June 2026
- GNOM · Global X Genomics & Biotechnology ETF4.68% weight · Holdings dated 31 May 2026
- SPYGX · Spyglass Growth Fund Institutional Shares4.32% weight · Holdings dated 30 June 2026
- ARKG · ARK Genomic Revolution ETF4.03% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- FBT · First Trust NYSE Arca Biotechnology Index Fund3.92% weight · Holdings dated 30 June 2026
- XMHQ · Invesco S&P MidCap Quality ETF3.55% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- BBH · VanEck Biotech ETF3.17% weight · Holdings dated 30 June 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 28 June 2026. Informational research, not investment advice.